Abstract

A convergent synthetic route to a tetrasaccharide related to PI-88, which allows the incorporation of a fluorescent BODIPY-label at the reducing-end, has been developed. The strategy, which features the use of 1,2-methyl orthoesters (MeOEs) as glycosyl donors, illustrates the usefulness of suitably-designed BODIPY dyes as glycosyl labels in synthetic strategies towards fluorescently-tagged oligosaccharides.

Highlights

  • The recognition of the crucial role of heparanase enzyme, an endo-β-D-glucuronidase able to degrade heparan sulfate (HS) in the extracellular matrix and basement membranes, in a number of pathological processes, such as metastasis and angiogenesis, has triggered the development of heparanase inhibitors [1,2,3,4,5,6]

  • Fluorescent labeling of biomolecules has been recognized as a research topic of great significance, since such labeling facilitates the investigation of glycoconjugates and their interaction in biological systems at high sensitivity [8,9,10,11,12]

  • We thought it would be of interest to investigate the feasibility of a synthetic approach to BODIPY-labeled PI-88 saccharide components, where the fluorescent dye is incorporated from the beginning of the synthetic sequence

Read more

Summary

Introduction

The recognition of the crucial role of heparanase enzyme, an endo-β-D-glucuronidase able to degrade heparan sulfate (HS) in the extracellular matrix and basement membranes, in a number of pathological processes, such as metastasis and angiogenesis, has triggered the development of heparanase inhibitors [1,2,3,4,5,6]. Several reasons can be cited for this preference: their high fluorescent quantum yields (∅), excellent photochemical and chemical stabilities, and, arguably, the relatively facile modulation of their photophysical and/or chemical properties by means of synthetic postfunctionalization of their indacene core [13,14,15,16,17,18] Based on these precedents, we thought it would be of interest to investigate the feasibility of a synthetic approach to BODIPY-labeled PI-88 saccharide components, where the fluorescent dye is incorporated from the beginning of the synthetic sequence. In light of some reported literature precedents [20], the incorporation of the lipophilic BODIPY core to the saccharidic ensemble could lead to ameliorated biological activity in the ensuing saccharides In this Article, we report a synthetic approach to a PI-88 tetrasaccharide analogue [21] featuring the use of 1,2-methyl orthoester (MeOE).

Results
SPh of PI-88 tetrasaccharide analogue
Regioselective glycosylation of triol
Registered
General Information
General Procedures
Procedure D
Mannopyranosyl BODIPY 12
Mannopyranosyl BODIPY 13
Mannopyranosyl BODIPY 14
Mannopyranosyl BODIPY 5
BODIPY Disaccharide 16a
BODIPY-Disaccharide Tetraol 16b
BODIPY-Disaccharide Silylated Triol 6
4.3.10. Thioglycosyl Disaccharide 8
4.3.12. BODIPY-Tetrasaccharide 10

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.